Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
Trump Presses Japan to Support Iran War Effort, Cites Pearl Harbor in Surprise Defense 
Brazil's Haddad Leaves Finance Ministry to Run for São Paulo Governor 
Ukraine-U.S. Peace Talks Continue in Florida as Zelenskiy Pushes for Diplomatic Progress 
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market 
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing 
Trump Signals End of U.S. Military Campaign Against Iran as Markets Rally 
Ukraine-U.S. Peace Talks Resume in Florida Amid Ongoing Russia-Ukraine War 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology 
Taiwan Strengthens Deterrence Amid Ongoing Chinese Military Threat 
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
